| # | Drug | Count |
|---|---|---|
| 0 | EVEROLIMUS | 24 |
| 1 | AMLODIPINE | 17 |
| 2 | LANREOTIDE ACETATE | 16 |
| 3 | ADALIMUMAB | 15 |
| 4 | NIRAPARIB | 15 |
| 5 | ONDANSETRON HYDROCHLORIDE | 15 |
| 6 | RANITIDINE | 15 |
| 7 | METFORMIN | 14 |
| 8 | PREDNISONE | 14 |
| 9 | BEVACIZUMAB | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EPHEDRINE SULFATE | 1 | 0.0046 |
| 1 | TRASTUZUMAB-DKST | 1 | 0.0036 |
| 2 | FLUDEOXYGLUCOSE F-18 | 1 | 0.0035 |
| 3 | DIMETICONE | 1 | 0.0035 |
| 4 | THROMBIN HUMAN AND FIBRINOGEN | 1 | 0.0030 |
| 5 | TOREMIFENE CITRATE | 1 | 0.0023 |
| 6 | LAROTRECTINIB | 2 | 0.0022 |
| 7 | LANREOTIDE ACETATE | 16 | 0.0020 |
| 8 | SELUMETINIB | 3 | 0.0018 |
| 9 | PSYLLIUM HUSK | 2 | 0.0015 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 51 |
| 1 | Corticosteroid [EPC] | 31 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 26 |
| 3 | mTOR Inhibitor Immunosuppressant [EPC] | 25 |
| 4 | Platinum-based Drug [EPC] | 23 |
| 5 | Dihydropyridine Calcium Channel Blocker [EPC] | 19 |
| 6 | Benzodiazepine [EPC] | 18 |
| 7 | Calcium Channel Blocker [EPC] | 17 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 16 |
| 9 | Serotonin-3 Receptor Antagonist [EPC] | 15 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 1 | Actinomycin [EPC] | 1 | 0.0005 |
| 2 | Radioactive Diagnostic Agent [EPC] | 1 | 0.0003 |
| 3 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 4 | Human alpha-1 Proteinase Inhibitor [EPC] | 1 | 0.0002 |
| 5 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |
| 6 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |
| 7 | Bismuth [EPC] | 1 | 0.0002 |
| 8 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 9 | Bile Acid Sequestrant [EPC] | 2 | 0.0002 |